Bullish
Cocrystal Pharma Releases Q1 2026 Financial Results
Cocrystal Pharma, Inc. (COCP) reported its Q1 2026 financial results, showing a narrower net loss of $2.3 million or $0.17 per share, an improvement f...
COCP
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest COCP News
Bullish
Research COCP on:
Ad Space